JD, C., M, Z., M, K., B, T., & S, D. (2020). Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies. Clinical pharmacokinetics, 59(4), 463. https://doi.org/10.1007/s40262-019-00823-8
Chicago Style (17th ed.) CitationJD, Clements, Zhu M, Kuchimanchi M, Terminello B, and Doshi S. "Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies." Clinical Pharmacokinetics 59, no. 4 (2020): 463. https://doi.org/10.1007/s40262-019-00823-8.
MLA (9th ed.) CitationJD, Clements, et al. "Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies." Clinical Pharmacokinetics, vol. 59, no. 4, 2020, p. 463, https://doi.org/10.1007/s40262-019-00823-8.